David Jamil Hadad

Statistics

Publications

Citations

2.2K

H-Index

Active since

1998

Affiliations

Universidade Federal do Espírito Santo(Current)

Case Western Reserve University

Rutgers, The State University of New Jersey

Boston Medical Center

University School

David Jamil Hadad is an author at Universidade Federal do Espírito Santo specializing in infectious diseases, pulmonary tuberculosis, and tuberculosis diagnosis.

ORCID

Publications per year

1998–2021

Publications

Biodegradation of polyethylene by the thermophilic bacterium Brevibacillus borstelensis

David Jamil Hadad, Shimona Geresh, A. Sivan · Journal of Applied Microbiology · 2005 · 640 citations

Life Sciences, Biotechnology, Microbiology +17

Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

John L. Johnson, David Jamil Hadad, W. Henry Boom et al. · PubMed · 2006 · 203 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Cavitary Disease and Quantitative Sputum Bacillary Load in Cases of Pulmonary Tuberculosis

Moisés Palaci, Reynaldo Dietze, David Jamil Hadad et al. · Journal of Clinical Microbiology · 2007 · 197 citations

Life Sciences, Infectious Diseases, Microbiology +12

Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis

Charles A. Peloquin, David Jamil Hadad, Lucilia Pereira Molino et al. · Antimicrobial Agents and Chemotherapy · 2007 · 187 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary Tuberculosis

Reynaldo Dietze, David Jamil Hadad, Bryan McGee et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 164 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

1–5 of 25